The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 |
|---|---|
| Net loss | -89,487,606 |
| Stock-based compensation | 2,084,499 |
| Bad debt expense | 13,347 |
| Depreciation | 42,855 |
| Loss on extinguishment of debt | -14,454,485 |
| Loss on acquisition of nakamoto | 59,743,812 |
| Amortization of debt discounts | 9,551 |
| Realized loss on digital assets | 1,411,204 |
| Change in fair value of put option liability-related party | 21,845,000 |
| Unrealized loss from digital assets | -22,105,029 |
| Unrealized loss on investments | 948,635 |
| Amortization of right-of-use assets | 128,407 |
| Amortization of capitalized software | 622,720 |
| Common stock issued to employees | 45,760 |
| Common stock issued for services | 22,403 |
| Loss on disposal of property and equipment | -6,434 |
| Accounts receivable | -23,173 |
| Inventories | -4,300 |
| Prepaid expenses and other current assets | 2,675,507 |
| Security deposits | 1,275 |
| Accounts payable accrued expenses | -1,596,538 |
| Customer deposits | -1,950 |
| Lease liability | -107,986 |
| Net cash used in operating activities | -15,943,968 |
| Proceeds from sale of digital assets | 40,000,110 |
| Capitalized software, net | 234,382 |
| Purchase of digital assets | 681,247,326 |
| Investments in unconsolidated affiliates | 45,007,992 |
| Cash acquired in acquisition of nakamoto | 188,569 |
| Net cash used in investing activities | -686,301,021 |
| Net proceeds from issuance of notes payable | 191,850,000 |
| Proceeds from loan payable | 203,017,500 |
| Proceeds from issuance of common stock related to pipe financings | 518,080,468 |
| Proceeds from issuance of common stock issued for at-the-market offering | 5,659,976 |
| Proceeds from issuance of common stock related to exercise of warrants | 9,216,534 |
| Repurchase of treasury stock | 9,557 |
| Repayments of notes payable | 648,828 |
| Repayments of convertible notes payable | 203,000,000 |
| Repayments of finance lease liabilities | 9,645 |
| Net cash provided by financing activities | 724,156,448 |
| Net change in cash and cash equivalents | 21,911,459 |
| Cash and cash equivalents at beginning of period | 2,273,624 |
| Cash and cash equivalents at end of period | 24,185,083 |
Kindly MD, Inc. (NAKAW)
Kindly MD, Inc. (NAKAW)